International Journal of Drug Delivery International Journal of Drug Delivery 3 (2011) 194-208
Total Page:16
File Type:pdf, Size:1020Kb
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by International Journal of Drug Delivery International Journal of Drug Delivery 3 (2011) 194-208 http://www.arjournals.org/index.php/ijdd/index Review ISSN: 0975-0215 A review on factors affecting the design of nasal drug delivery system Ram Chand Dhakar1, Sheo Datta Maurya1, Vijay K Tilak1, Anish K Gupta2 *Corresponding author: Abstract Transmucosal nasal delivery is a promising drug delivery Ram Chand Dhakar option where common drug administrations (e.g., intravenous, 1. Dept. of Pharmacy, IEC, College intramuscular, or oral) are inapplicable. Recently, it has been of Eng. & Technology, KP-1, G. shown that many drugs have better bioavailability by nasal Noida, INDIA -201308 route than by oral route. This has been attributed to rich E-mail: [email protected] vasculature and a highly permeable structure of the nasal Mob. +91-9310440484 mucosa coupled with avoidance of hepatic first-pass 2. Amarnath pharmaceuticals, elimination, gut wall metabolism and/or destruction in the Pandicheri, INDIA-605001 gastrointestinal tract. The physiology of the nose presents obstacles, but offers a promising route for non-invasive systemic delivery of numerous therapies and debatably drug delivery route to the brain. To overcoming problems in nasal drug delivery requires deep understanding of the various factors affecting nasal delivery. Thus present review focuses on various aspects of nasal drug delivery with special emphasis to factors affecting nasal drug administration. Keywords: Transmucosal nasal delivery, hepatic first-pass metabolism, non-invasive, microemulsions, microspheres. Introduction subject variability in mucus secretion in the nasal Oral drug delivery is the most desirable route for mucosa could significantly effect drug absorption drug administration whenever systemic effects from this site. are intended [1, 2]. But low oral bioavailability of some compounds has prompted the search of Currently, many nasal drug products on the more effective routes for their systemic delivery market are indicated for the treatment of local [3]. Transmucosal routes of drug delivery (i.e., disease such as allergic rhinitis, pain and for the mucosal linings of the nasal, rectal, vagina, centrally acting drugs where the direct pathway ocular and oral cavity) offer distinct advantages from the nose to brain might offer a quicker and over peroral administration for systemic drug further specific therapeutic effect. Many low- delivery. These advantages includes possible molecular-weight, non-polar drugs (<300Da) in bypass of the first pass effect, avoidance of pre- solution form are able to infiltrate the nasal systemic elimination of gastro intestinal tract and epithelium with effortlessness. The effectiveness depending on the particular drug. The nasal of a particular delivery system is also affected by cavity as a site for systemic drug delivery has its formulation as a liquid, powder [4], gel [5], been investigated by many research groups. microsphere [6], liposome [7] or nanoparticle [8]. However, the potential irritation and irreversible Intranasal drug delivery is now recognized to be a damage to the ciliary action application of nasal useful and reliable alternative to oral and dosage forms, as well as the large intra and inter parenteral routes. In general, among the primary targets for intranasal administration are Dhakar et al. International Journal of Drug Delivery 3 (2011) 194-208 pharmacologically active compounds with poor Nasal anatomy and physiology of nose: stability in gastrointestinal fluids, poor intestinal The human nasal cavity has a total volume of absorption and/or extensive hepatic first-pass about 16 to 19 ml, and a total surface area of elimination, such as peptides, proteins and polar about 180 cm2, and is divided into two nasal drugs [9]. The nasal delivery seems to be a cavities via the septum. The volume of each favorable way to circumvent the obstacles for cavity is approximately 7.5 ml, having a surface blood-brain barrier (BBB) allowing the direct area around 75 cm2. drug delivery in the biophase of central nervous system (CNS)-active compounds. It has also been The vestibular region: It is located at the considered to the administration of vaccines [10- opening of nasal passages and is responsible for 13]. filtering out the air borne particles. It is considered to be the least important of the three regions with regard to drug absorption. The respiratory region: The respiratory region is the largest having the highest degree of vascularity and is mainly responsible for systemic drug absorption. The olfactory region: It is of about 10 cm2 in surface area, and it plays a vital role in transportation of drugs to the brain and the CSF. Human olfactory region comprises of thick connective tissue lamina propria, upon which rests the olfactory epithelium. Lamina propria has axons, bowans bundle and blood vessels whereas epithelium consists of three different cells i.e. basal cells, supporting cells and olfactory Fig : 1 receptor cells. Neurons are interspersed between supporting cells. The olfactory receptor cells are In addition, intranasal absorption avoids the bipolar neurons with a single dendritic and gastrointestinal and hepatic pre-systemic extending from the cell body to the free apical metabolism, enhancing drug bioavailability in surface where it ends in an olfactory knob comparison with that obtained after carrying non-motile cilia, which extend above the gastrointestinal absorption [14,15]. Hence, it epithelium. appears to be an appropriate route for the treatment of not only acute or chronic nasal The epithelium of the nasal passage is covered by diseases, but also for a range of acute or chronic a mucus layer, which entraps particles. The conditions requiring considerable systemic drug mucus layer is cleared from the nasal cavity by exposure [9]. cilia, and is renewed every 10 to 15 minutes [17]. The pH of the mucosal secretions ranges from 5.5 The present review outlines anatomical and to 6.5 in adults and 5.0 to 6.7 in children. The physiological features of nasal cavity, the major mucus moves through the nose at an approximate factors affecting nasal drug delivery. rate of 5 to 6 mm/min resulting in particle Additionally, this review focuses on the strategies clearance within the nose every 15 to 20 minutes. used to enhance the nasal drug absorption and Numerous enzymes for instance, cytochrome research carried out on nasal drug delivery. 195 Dhakar et al. International Journal of Drug Delivery 3 (2011) 194-208 P450 enzymes, carboxylesterases and glutathione proposed but the following two mechanisms have S-transferases are found in nasal cavity[18-20]. been considered predominantly. Reason for Development of Nasal Delivery Nasal drug delivery is a useful delivery method for drugs that are active in low doses and show no or minimal oral bioavailability. The nasal route circumvents hepatic first pass elimination associated with the oral delivery: it is easily accessible and suitable for self-medication. Currently, tow classes of nasally delivered Figure 2: (1) Paracellular route (1a) Intercellular spaces, therapeutics are on the market. The first one (1b) Tight junctions, (2) Transcellular route (2a) Passive comprises low molecular weight and hydrophobic diffusion, (2b) Active transport, (3) Transcytosis (modified)25 drugs for the treatment of the nasal mucosa and sinus, including decongestants, topical steroids, The first mechanism involves an aqueous route of antibiotics and other (OTC) products. The second transport, which is also known as the paracellular class encompasses a few drugs, which have route. This route is slow and passive. Insulin, sufficient nasal absorption for displaying mannitol and propranolol were absorbed through systemic effects. Important candidates are the this mechanism. There is an inverse log-log compounds, generally administered by injection correlation between intranasal absorption and the and hardly absorbed after oral administration, due molecular weight of water-soluble compounds. to their instability in gastrointestinal tract, poor Literature survey revealed that good absorption properties, and their rapid and bioavailability was observed for drugs with a extensive biotransformation [21-23]. molecular weight up to 1000 Daltons. But with Mechanism of drug absorption through nasal the help of permeation enhancers good bioavailability can be enhanced to at least 6000 mucosa: 26 The first step in the absorption of drug from the Daltons . The second mechanism involves nasal cavity is passage through the mucus [22]. transport through a lipoidal route that is also Small, unchanged particles easily pass through known as the transcellular process and is this layer. However, large or charged particles responsible for the transport of lipophilic drugs may find it more difficult to cross. Mucin, the that show a rate dependency on their principle protein in the mucus, has the potential lipophilicity. Drugs also cross cell membranes by to bind to solutes, hindering diffusion. an active transport route via carrier-mediated Additionally, structural changes in the mucus means or transport through the opening of tight layer are possible as a result of environmental junctions [23]. For example, Chitosan, a natural changes (i.e. pH, temperature, etc.)[24]. biopolymer from shellfish, opens tight junctions Subsequent to a drug’s passage through the between epithelial cells to facilitate drug mucus,